Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06354582

Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia

Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia : A Randomized Controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Kunyue Li · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study aims to explore the effect of intravenous vitamin C infusion on intrapartum fever after epidural labor analgesia, to reduce the impact of intrapartum fever on maternal and infant, improve maternal and infant outcomes, and provide a reference for clinical preventive medication.

Detailed description

Parturients who request pain relief would receive epidural labor analgesia after the obstetrician and anesthesiologist jointly evaluated and approved. The epidural catheter was inserted at the intervertebral space of either L2-3 or L3-4. 5 ml 1.5% chloroprocaine (with 1:200,000 epinephrine) as a test was delivered to parturients via the catheter. Then parturients would be observed for 5 min whether there were adverse reactions and then were given an initial dose of 10 ml ropivacaine 0.08% with sufentanil 0.3 µg/ml. After that, a patient-controlled epidural analgesia (PCEA) pump (240ml 0.08% ropivacaine with sufentanil 0.3 µg/ml) would be attached to the catheter. The pump would be set to administer an 8 ml bolus every 20 minutes and a 2 ml patient-controlled bolus with the same interval. Subsequently, trained nursing staff would take charge of the parturients and inform the obstetrician. The basic condition of parturients was monitored during the whole process. After that, parturients in each group will be administered vitamin C intravenously except the group for placebo-controlled.

Conditions

Interventions

TypeNameDescription
DRUGVitamin C InjectionDrug Specification: 5ml: 1g. Method: parturients in each group will be intravenously injected with corresponding dose after receiving epidural labor analgesia.
OTHERNormal salineThe placebo comparator will receive normal saline with the same volume and be administered after the induction of epidural labor anesthesia.

Timeline

Start date
2024-04-15
Primary completion
2024-10-01
Completion
2024-10-01
First posted
2024-04-09
Last updated
2024-07-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06354582. Inclusion in this directory is not an endorsement.